Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
2088.9000 -24.20 (-1.15%)
NSE Jan 08, 2026 15:00 PM
Volume: 355.5K
 

announcement
Conference/Earnings Calls Alerts
logo
Glenmark Pharmaceuticals Ltd.
18 Aug 2025
2088.90
-1.15%
Glenmark Pharmaceuticals Results Earnings Call for Q1FY26
Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
More from Glenmark Pharmaceuticals Ltd.
Recommended
Market trades lower, HUDCO signs a Rs 1 lakh crore MoU with Chhattisgarh
Trendlyne Marketwatch | 08 Jan 2026, 02:45PM
Don't be boring, unless you are an investor
The Baseline | 07 Jan 2026, 07:39PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
| 29 Jun 2020